期刊文献+

注射用前列腺素E_1治疗不稳定型心绞痛的疗效观察 被引量:3

Curaite effect observation of prostate E_1 injection treeting instable angici
下载PDF
导出
摘要 目的探讨注射用前列腺素E1(凯时注射液)治疗不稳定型心绞痛的效果。方法将病人随机分为治疗组(30例)和对照组(30例)。治疗组用凯时注射液10μg加入0.85%生理盐水中稀释后缓慢静脉推注,每天1次,10d为一疗程。对照组除不用凯时注射液外,其他治疗方法与治疗组相同。治疗前后观察心绞痛发作情况,静息心电图变化的情况。结果治疗组显效24例,有效4例,无效2例,总有效率93.3%。两组总有效率差异有显著性(P<0.05)。结论凯时注射液对不稳定型心绞痛患者疗效显著。 Objective The effect of prostate E1 injection ( Kaishi injection ) treating instable angina was discussed. Methods Patients were distributed randomly to a treatment group (30case) and a comparison group (30case). Kaishi injection added to 0.85% sodium chloride to be diluted and was used in the treatment group. It was injected slowly intravenously once each day and 10days is a period of treatment. The other treat method of comparison group is the same as that of treatment group except doing without Kaishi injection. The angina outbreak instance and changes of rest cardiogram before and after the treatment were observed. Results In treatment group the effect of 24cases was remarkable, 4cases was effectual and 2cases was of no effect. The total efficiency rate is 93.3%. The difference of total efficiency rate between both groups is distinct ( P 〈 0.05 ). Conclusion The curative effect of Kaishi injection on instable angina is notable.
出处 《临床和实验医学杂志》 2009年第1期100-101,共2页 Journal of Clinical and Experimental Medicine
关键词 前列腺E1 不稳定型心绞痛 疗效 Prostate E1 Instable angina Effect
  • 相关文献

参考文献2

二级参考文献4

  • 1潘宜智,吾柏铭,洪小苏,张莉丽,刘励军,陈建昌,高岚.血小板活化在不稳定性心绞痛中的意义[J].中华心血管病杂志,1994,22(4):247-248. 被引量:35
  • 2徐叔云等.药理实验方法学[M]人民卫生出版社,1991.
  • 3刘忠铭,戴绍东,林国珍,卢尔滨,高长斌,赵林阳,魏大愚.治疗冠心病的临床总结[J]临床心血管病杂志,1987(02).
  • 4胡琛.前列腺素与冠心病[J]临床内科杂志,1985(01).

共引文献43

同被引文献21

  • 1兰艳莉,毛君晓,李桂英.护理干预对前列腺素E_1治疗冠心病心绞痛副作用的影响[J].赣南医学院学报,2005,25(5):696-697. 被引量:1
  • 2李志平,范士志,蒋耀光,王如文,陈建明,牛会军,何勇,郭伟,沈诚.风心病合并肺动脉高压体外循环后前列腺素E_1抵抗现象的研究[J].第三军医大学学报,2007,29(9):792-795. 被引量:3
  • 3马平霞,段美容,李玲.前列腺素E1治疗肺动脉高压时不良反应的观察及护理[J].中国误诊学杂志,2007,7(14):3313-3314. 被引量:6
  • 4黄霞丽,陈世厚,袁艳.外涂丁卡因预防静脉滴注前列腺素E_1不良反应效果观察[J].临床误诊误治,2007,20(5):89-90. 被引量:1
  • 5Heider P, Wildgruber M, Wolf O, et al. Improvement of microcireulation after percutaneous transluminal angioplasty in the lower limb with prostaglandin E1 [J]. Prostaglandins Other Lipid Mediat, 2009, 88(1-2): 23-30.
  • 6Wu CC, Wu CI, Wang WY, et al. Low concentrations of resveratrol potentiate the antiplatelet effect of prostaglandins[J].Planta Med, 2007, 73(5): 439-443.
  • 7Gensch C, Clever Y, Werner C, et al. Regulation of endothelial progenitor cells by prostaglandin E1 via inhibition of apoptosis[J]. J Mol Cell Cardiol, 2007, 42(3): 670-677.
  • 8Mehrabi MR, Serbecic N, Tamaddon F, et al. Clinical and experimental evidence of prostaglandin E 1-induced angiogenesis in the myocardium of patients with ischemic heart disease[J]. Cardiovasc Res, 2002, 56(2): 214-224.
  • 9Mehrabi MR, Serbecic N, Tamaddon F, et al. Clinical benefit of prostaglandin El-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium[J]. Biomed Pharmacother, 2003, 57(3-4): 173-178.
  • 10von Scheidt W, Costard-Jaeckle A, Stempfle M, et al. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study[J]. J Heart Lung Transplant, 2006, 25(9): 1070-1076.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部